ADIPOQ and Alzheimer disease: St Studies have shown that circulating adiponectin levels are decreased in mild cognitive impairment and AD (Teixeira et al., 2013) and that tail vein injection of adiponectin-overexpressing endothelial progenitor cells can improve cognitive function in aging rats (Huang J. et al., 2020).